Akebia Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	160.18	194.62	292.48	211.65	294.64	Upgrade
Revenue Growth (YoY)	-17.70%	-33.46%	38.19%	-28.17%	-12.05%	Upgrade
Cost of Revenue	26.15	39.76	22.5	81.49	63.96	Upgrade
Gross Profit	134.03	154.86	269.99	130.16	230.68	Upgrade
Selling, General & Admin	106.55	100.23	138.6	174.14	154.1	Upgrade
Research & Development	37.65	63.08	129.99	147.85	218.49	Upgrade
Operating Expenses	180.24	199.35	304.63	358.03	405.2	Upgrade
Operating Income	-46.21	-44.5	-34.64	-227.88	-174.52	Upgrade
Interest Expense	-18.19	-6.03	-15.69	-20.02	-8.92	Upgrade
Interest & Investment Income	-	-	-	0.07	-	Upgrade
Other Non Operating Income (Expenses)	-0.24	0.89	3.15	2.41	1.86	Upgrade
EBT Excluding Unusual Items	-64.63	-49.64	-47.18	-245.42	-181.58	Upgrade
Merger & Restructuring Charges	-0.06	-0.18	-15.93	-21.58	-68.24	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	0.02	0.05	Upgrade
Asset Writedown	-4.21	-1.58	-30.24	-15.05	-135.07	Upgrade
Other Unusual Items	-0.52	-0.52	-0.87	-	-	Upgrade
Pretax Income	-69.41	-51.93	-94.23	-282.02	-384.84	Upgrade
Net Income	-69.41	-51.93	-94.23	-282.02	-384.84	Upgrade
Net Income to Common	-69.41	-51.93	-94.23	-282.02	-384.84	Upgrade
Shares Outstanding (Basic)	211	187	183	166	138	Upgrade
Shares Outstanding (Diluted)	211	187	183	166	138	Upgrade
Shares Change (YoY)	12.53%	2.56%	10.14%	19.85%	16.95%	Upgrade
EPS (Basic)	-0.33	-0.28	-0.52	-1.70	-2.78	Upgrade
EPS (Diluted)	-0.33	-0.28	-0.52	-1.70	-2.78	Upgrade
Free Cash Flow	-40.69	-23.38	-73.27	-253.02	-110.71	Upgrade
Free Cash Flow Per Share	-0.19	-0.13	-0.40	-1.52	-0.80	Upgrade
Gross Margin	83.68%	79.57%	92.31%	61.50%	78.29%	Upgrade
Operating Margin	-28.85%	-22.86%	-11.84%	-107.67%	-59.23%	Upgrade
Profit Margin	-43.33%	-26.68%	-32.22%	-133.25%	-130.61%	Upgrade
Free Cash Flow Margin	-25.40%	-12.02%	-25.05%	-119.55%	-37.57%	Upgrade
EBITDA	-8.7	-6.87	3.06	-189.91	-139.83	Upgrade
EBITDA Margin	-5.43%	-3.53%	1.04%	-89.73%	-47.46%	Upgrade
D&A For EBITDA	37.5	37.63	37.7	37.97	34.69	Upgrade
EBIT	-46.21	-44.5	-34.64	-227.88	-174.52	Upgrade
EBIT Margin	-28.85%	-22.86%	-11.84%	-107.67%	-59.23%	Upgrade
Revenue as Reported	160.18	194.62	292.48	211.65	294.64	Upgrade
Advertising Expenses	4.6	1	6.7	8.2	5	Upgrade

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q